Renascience Inc. (4889.T)

JPY 1016.0

(-1.65%)

Annual Income Statements

(In JPY)
Breakdown 2024 2023 2022 2021 2020
Revenue 194.16 Million 100.54 Million 139.33 Million 209.8 Million 72 Million
Cost of Revenue 28.52 Million 250 Thousand 58.36 Million 29.97 Million 20 Million
Gross Profit 165.64 Million 100.29 Million 80.97 Million 179.82 Million 52 Million
Operating Expenses 416.14 Million 434.16 Million 291.81 Million 265.95 Million 236 Million
Selling, General and Administrative Expenses 167 Million 185 Million 193 Million 265 Million 235 Million
Research and Development Expenses 236 Million 235 Million 82 Million 81.43 Million 26 Million
Other Expenses 40 Thousand 5000.00 42 Thousand 1.75 Million -5.73 Million
Cost and Expenses 446.5 Million 434.41 Million 350.17 Million 295.92 Million 256 Million
Operating Income -252.33 Million -333.87 Million -210.83 Million -86.12 Million -183 Million
Interest Expense - - 5.36 Million 7.5 Million 678 Thousand
Income Tax Expense 1.95 Million 1.95 Million 1.2 Million 296 Thousand -1 Million
Earnings before Tax -256.37 Million -333.83 Million -253.08 Million -99.75 Million -184 Million
Net Income -258.33 Million -335.79 Million -254.29 Million -100.05 Million -184 Million
Earnings Per Share Basic -20.32 -26.42 -22.33 -10.19 -15.00
Earnings Per Share Diluted -20.32 -26.42 -22.33 -10.19 -15.00
Weighted Average Shares Outstanding 12.71 Million 12.71 Million 11.38 Million 9.81 Million 12.26 Million
Weighted Average Shares Outstanding (Diluted) 12.71 Million 12.71 Million 11.38 Million 9.81 Million 12.26 Million
Gross Margin 0.85 1.00 0.58 0.86 0.72
EBIT Margin -1.29 -3.31 -1.67 -0.38 -0.01
Profit Margin -1.33 -3.34 -1.83 -0.48 -2.56
EBITDA -251 Million -332.49 Million -244.64 Million -80.35 Million -180.08 Million
Earnings Before Tax Margin -1.30 -3.32 -1.51 -0.41 -2.54

Income Statement Charts